---
title: "Maiwei Bio (2493.HK) Spikes on Short-Term Rally"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285328892.md"
description: "MABWELL-B (2493.HK) is currently priced at HK$27.100, down -0.51% for the day, with a 5-minute intraday increase of over 3%, and a market capitalization of HKD 12.3 billion. The company focuses on the research and development of innovative drugs, with short-term capital driving the stock price up during the trading session. There have been no major announcements recently, and the fluctuations may be related to active trading and market interest in the innovative pipeline"
datetime: "2026-05-06T07:21:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285328892.md)
  - [en](https://longbridge.com/en/news/285328892.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285328892.md)
---

# Maiwei Bio (2493.HK) Spikes on Short-Term Rally

Maiwei Bio-B (2493.HK) traded at HK$27.100, down **\-0.51%** today, with a 3% spike over a 5-minute intraday period and a market cap of HK$12.3 billion.

Maiwei focuses on innovative pharmaceuticals. The intraday rally was driven by short-term trading activity. No major news recently; movement may reflect active turnover and investor interest in the company’s drug pipeline.

\---

### Related Stocks

- [02493.HK](https://longbridge.com/en/quote/02493.HK.md)

## Related News & Research

- [Mabwell Wins Wider China Indications for Denosumab Biosimilar as Global Push Accelerates](https://longbridge.com/en/news/287103520.md)
- [Mabwell Plans Up to RMB 1 Billion Targeted Debt Issue to Reshape Capital Structure](https://longbridge.com/en/news/285408743.md)
- [Some May Be Optimistic About Coloplast's (CPH:COLO B) Earnings](https://longbridge.com/en/news/287005062.md)
- [Release according to article 135 section 2 BörseG](https://longbridge.com/en/news/286754366.md)
- [New York Governor Signs Bills To Preserve Mandatory Vaccines](https://longbridge.com/en/news/286947583.md)